Skip to main content
Erschienen in: Supportive Care in Cancer 11/2023

01.11.2023 | Review

Barriers and facilitators to physical activity in cancer survivors with pain: a systematic review

verfasst von: Sophie Van Dijck, An De Groef, Janan Kothari, Lore Dams, Vincent Haenen, Nathalie Roussel, Mira Meeus

Erschienen in: Supportive Care in Cancer | Ausgabe 11/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Pain post-treatment is a debilitating symptom in the growing population of cancer survivors. While physical activity is an integral part of pain management, low levels of physical activity are often observed in this population. The aim of this systematic review is to gain insight into the barriers and facilitators to physical activity in cancer survivors afflicted with pain.

Methods

In December 2021, a systematic search was conducted using PubMed and Web of Science. All studies exploring barriers and/or facilitators to physical activity in cancer survivors with pain were included. The methodological quality of the evidence was appraised with the Mixed Methods Appraisal Tool (version 2018).

Results

Six articles were included. Current literature was limited and mostly focused on female breast cancer survivors. The identified barriers and facilitators could be categorized into six different domains: the logistical, symptoms, cognitive, clinical, social, and knowledge domain. The barrier of pain was reported as a barrier on its own that is closely linked to other barriers in this specific population.

Conclusion

Barriers and facilitators to physical activity were categorized in six different domains. The barrier of pain distinguishes itself and brings along additional obstacles such as anxiety, fear, and avoidance behavior. Current evidence is limited and focuses mostly on female breast cancer survivors. Further research in larger cohorts representing various subsets of cancer survivors with pain is warranted, as well as studies that implement these insights in physical activity interventions.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
30.
Zurück zum Zitat Straus SE, Tetroe J, Graham ID (2013) Knowledge Translation in Health Care: Moving from Evidence to Practice, 2nd edn. John Wiley & Sons LtdCrossRef Straus SE, Tetroe J, Graham ID (2013) Knowledge Translation in Health Care: Moving from Evidence to Practice, 2nd edn. John Wiley & Sons LtdCrossRef
32.
Zurück zum Zitat World Health Organisation (2018) More Active People for a Healthier World, Global Action Plan on Physical Activity 2018–2030, Geneva. World Health Organization, UK World Health Organisation (2018) More Active People for a Healthier World, Global Action Plan on Physical Activity 2018–2030, Geneva. World Health Organization, UK
33.
35.
Zurück zum Zitat Hong QN, Pluye P, Fàbregues S, Bartlett G, Boardman F, Cargo M, Dagenais P, Gagnon M-P, Griffiths F, Nicolau B, O’Cathain A, Rousseau MC, Vedel I (2018) Mixed Methods Appraisal Tool (MMAT), version, 2018. Registration of Copyright (#1148552), Canadian Intellectual Property Office, Industry Canada Hong QN, Pluye P, Fàbregues S, Bartlett G, Boardman F, Cargo M, Dagenais P, Gagnon M-P, Griffiths F, Nicolau B, O’Cathain A, Rousseau MC, Vedel I (2018) Mixed Methods Appraisal Tool (MMAT), version, 2018. Registration of Copyright (#1148552), Canadian Intellectual Property Office, Industry Canada
39.
44.
Zurück zum Zitat Cunningham SJ, Patton M, Schulte F, Richardson PA, Heathcote LC (2021) Worry about somatic symptoms as a sign of cancer recurrence: prevalence and associations with fear of recurrence and quality of life in survivors of childhood cancer. Psychooncology 30(7):1077–1085. https://doi.org/10.1002/pon.5647CrossRefPubMed Cunningham SJ, Patton M, Schulte F, Richardson PA, Heathcote LC (2021) Worry about somatic symptoms as a sign of cancer recurrence: prevalence and associations with fear of recurrence and quality of life in survivors of childhood cancer. Psychooncology 30(7):1077–1085. https://​doi.​org/​10.​1002/​pon.​5647CrossRefPubMed
47.
Zurück zum Zitat De Groef A, Evenepoel M, Van Dijck S et al (2023) Feasibility and pilot testing of a personalized eHealth intervention for pain science education and self-management for breast cancer survivors with persistent pain: a mixed-method study. Support Care Cancer 31(2):119. https://doi.org/10.1007/s00520-022-07557-7 De Groef A, Evenepoel M, Van Dijck S et al (2023) Feasibility and pilot testing of a personalized eHealth intervention for pain science education and self-management for breast cancer survivors with persistent pain: a mixed-method study. Support Care Cancer 31(2):119. https://​doi.​org/​10.​1007/​s00520-022-07557-7
Metadaten
Titel
Barriers and facilitators to physical activity in cancer survivors with pain: a systematic review
verfasst von
Sophie Van Dijck
An De Groef
Janan Kothari
Lore Dams
Vincent Haenen
Nathalie Roussel
Mira Meeus
Publikationsdatum
01.11.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 11/2023
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-023-08141-3

Weitere Artikel der Ausgabe 11/2023

Supportive Care in Cancer 11/2023 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.